Suppliers / Moehs

Moehs

Spain 233 employees 2 duplicate records merged Updated 9 July 2026

Moehs is an API manufacturer based in Spain. It holds 49 active US drug master files and 34 valid CEPs. Its GMP standing is certified by MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 24 November 2023 as VAI.

49
active US DMFs
34
valid CEPs
3
registered plants 2 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 24 November 2023 VAI US FDA
  • 18 May 2018 VAI US FDA
  • 22 September 2017 VAI US FDA
  • 26 February 2016 VAI US FDA
  • 9 May 2013 VAI US FDA
  • 12 February 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Spain, Spain 3002807632
Rubi, Spain Not on file
Spain, Spain 3003245787

What they file, and where

Molecule Regulators Docs
Lidocaine EDQM, SFDA (Saudi Arabia), US FDA 5
Metoprolol EDQM, SFDA (Saudi Arabia), US FDA 5
Prilocaine EDQM, SFDA (Saudi Arabia), US FDA 5
Carvedilol EDQM, SFDA (Saudi Arabia), US FDA 4
Acetylcysteine EDQM, SFDA (Saudi Arabia), US FDA 3
Amlodipine EDQM, SFDA (Saudi Arabia), US FDA 3
Bisoprolol EDQM, SFDA (Saudi Arabia), US FDA 3
Bupivacaine EDQM, SFDA (Saudi Arabia), US FDA 3
Nifedipine EDQM, SFDA (Saudi Arabia), US FDA 3
Quetiapine EDQM, SFDA (Saudi Arabia), US FDA 3
Show all 30 molecules on file
Rabeprazole EDQM, SFDA (Saudi Arabia), US FDA 3
Sitagliptin SFDA (Saudi Arabia), US FDA 3
Acebutolol EDQM, US FDA 2
Amantadine EDQM, US FDA 2
Articaine EDQM, US FDA 2
Carbocisteine EDQM, SFDA (Saudi Arabia) 2
Celiprolol EDQM, US FDA 2
Dexmedetomidine US FDA 2
Lansoprazole EDQM, US FDA 2
Mepivacaine EDQM, US FDA 2
Norepinephrine EDQM, US FDA 2
Pantoprazole EDQM, US FDA 2
Sotalol EDQM, US FDA 2
Sumatriptan US FDA 2
Triamterene EDQM, US FDA 2
Abrocitinib US FDA 1
Amlodipine Besilate EDQM 1
Choline Fenofibrate US FDA 1
Daridorexant US FDA 1
Deucravacitinib US FDA 1

Also appears on these molecule pages

Acetylcysteine contract manufacturing Amantadine contract manufacturing Amlodipine contract manufacturing Articaine contract manufacturing Bisoprolol contract manufacturing Bupivacaine contract manufacturing Carbocisteine API Carvedilol contract manufacturing Choline Fenofibrate API Deucravacitinib API Dexmedetomidine contract manufacturing Dronedarone contract manufacturing
Show 33 more molecule pages
Duloxetine contract manufacturing Elagolix API Entacapone contract manufacturing Fenofibrate contract manufacturing Irbesartan contract manufacturing Lansoprazole contract manufacturing Lasmiditan API Lidocaine contract manufacturing Lysine contract manufacturing Mavacamten API Mepivacaine contract manufacturing Metoprolol contract manufacturing Nifedipine contract manufacturing Norepinephrine API Obeticholic Acid API Olmesartan contract manufacturing Pantoprazole contract manufacturing Prilocaine contract manufacturing Pyrantel contract manufacturing Quetiapine contract manufacturing Rabeprazole contract manufacturing Relugolix API Rimegepant API Ropivacaine contract manufacturing Sertraline API Sotalol contract manufacturing Sumatriptan contract manufacturing Telmisartan contract manufacturing Trimebutine contract manufacturing Venlafaxine contract manufacturing Vericiguat API Zavegepant API Sitagliptin API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 5 None
MFDS (Korea) None 2
US FDA None 1

Questions about Moehs

Does Moehs hold a US DMF or a CEP?
Moehs holds 49 active US drug master files and 34 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Moehs FDA-registered?
2 sites operated by Moehs carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Moehs's last inspection go?
The most recent inspection on record closed on 24 November 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 6 inspections are on file.
Where does Moehs manufacture?
3 registered sites are on record, in Spain (Spain and Rubi among others). Every site is listed on this page with the register it came from.
What does Moehs make?
30 molecules are on record against Moehs, including Lidocaine, Metoprolol, Prilocaine and Carvedilol. Each links through to that molecule's full manufacturer list.
Which regulators recognise Moehs's GMP?
Current GMP certificates are on record from MFDS (Korea) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Moehs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 3 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 24 November 2023.

Comparable suppliers

Dr Reddy's Laboratories shares 16 molecules Hetero shares 13 molecules Apitoria Pharma shares 10 molecules Ipca Laboratories shares 9 molecules Macleods Pharmaceuticals shares 9 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates